AtriCure Inc
Change company Symbol lookup
Select an option...
ATRC AtriCure Inc
MLSS Milestone Scientific Inc
PG Procter & Gamble Co
UUUU Energy Fuels Inc
VLPNF voestalpine AG
CGC Canopy Growth Corp
MUE BlackRock MuniHoldings Quality Fund II, Inc.
GLBR Global Brokerage Inc
NUS NU Skin Enterprises Inc
TR Tootsie Roll Industries Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

AtriCure, Inc. provides technologies for the treatment of atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain. It develops, manufactures, and sells devices for the surgical ablation of cardiac tissue, systems designed for the exclusion of the left atrial appendage and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers. Its ablation and left atrial appendage management (LAAM) products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its products for appendage management include AtriClip System and LARIAT System.

Postmarket

Last Trade
Delayed
$42.08
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$42.08
Day's Change
0.75 (1.81%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
42.82
Day's Low
41.38
Volume
(Light)
Volume:
164,075

10-day average volume:
265,472
164,075

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.